Wei Wen

1.3k total citations
18 papers, 803 citations indexed

About

Wei Wen is a scholar working on Molecular Biology, Aging and Business and International Management. According to data from OpenAlex, Wei Wen has authored 18 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 3 papers in Aging and 2 papers in Business and International Management. Recurrent topics in Wei Wen's work include CRISPR and Genetic Engineering (13 papers), Pluripotent Stem Cells Research (8 papers) and RNA Interference and Gene Delivery (5 papers). Wei Wen is often cited by papers focused on CRISPR and Genetic Engineering (13 papers), Pluripotent Stem Cells Research (8 papers) and RNA Interference and Gene Delivery (5 papers). Wei Wen collaborates with scholars based in China, United States and United Kingdom. Wei Wen's co-authors include Xiao‐Bing Zhang, Tao Cheng, Jianping Zhang, Ya-Wen Fu, Guohua Li, Jing Xu, Wanqiu Chen, Weiping Yuan, David J. Baylink and Gary D. Botimer and has published in prestigious journals such as Nucleic Acids Research, Blood and Genome biology.

In The Last Decade

Wei Wen

18 papers receiving 792 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Wen China 13 737 198 98 69 68 18 803
Sandeep K. Botla Germany 5 912 1.2× 258 1.3× 176 1.8× 59 0.9× 95 1.4× 5 1.0k
Florence M. Chardon United States 8 742 1.0× 162 0.8× 123 1.3× 42 0.6× 58 0.9× 12 851
Emma Haapaniemi Finland 4 829 1.1× 260 1.3× 146 1.5× 57 0.8× 34 0.5× 6 934
Dong Woo Song South Korea 11 926 1.3× 235 1.2× 47 0.5× 47 0.7× 105 1.5× 17 1.0k
Alessandra Crippa Italy 6 439 0.6× 133 0.7× 121 1.2× 32 0.5× 33 0.5× 8 536
Jenna Persson Sweden 9 1.2k 1.6× 291 1.5× 166 1.7× 58 0.8× 45 0.7× 10 1.2k
Ya-Wen Fu China 10 637 0.9× 190 1.0× 81 0.8× 62 0.9× 24 0.4× 15 709
King L. Hung United States 8 588 0.8× 169 0.9× 112 1.1× 36 0.5× 78 1.1× 13 692
Beeke Wienert Australia 14 1.0k 1.4× 250 1.3× 63 0.6× 57 0.8× 49 0.7× 16 1.2k
Lin Ye United States 6 804 1.1× 297 1.5× 206 2.1× 30 0.4× 74 1.1× 8 912

Countries citing papers authored by Wei Wen

Since Specialization
Citations

This map shows the geographic impact of Wei Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Wen more than expected).

Fields of papers citing papers by Wei Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Wen. The network helps show where Wei Wen may publish in the future.

Co-authorship network of co-authors of Wei Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Wen. A scholar is included among the top collaborators of Wei Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Wen. Wei Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zhao, Mei, Feng Zhang, Zhi-Xue Yang, et al.. (2024). Decoding the complexity of on-target integration: characterizing DNA insertions at the CRISPR-Cas9 targeted locus using nanopore sequencing. BMC Genomics. 25(1). 189–189. 4 indexed citations
2.
Yang, Zhi-Xue, Ya-Wen Fu, Wei Wen, et al.. (2024). OliTag-seq enhances in cellulo detection of CRISPR-Cas9 off-targets. Communications Biology. 7(1). 696–696. 6 indexed citations
3.
Yang, Shuang, Haoyuan Li, Wei Wen, et al.. (2024). Mitochondrial tRNA pseudouridylation governs erythropoiesis. Blood. 144(6). 657–671. 10 indexed citations
4.
Wen, Wei, Xinyi Shen, Huayu Li, et al.. (2023). Enhancing cord blood stem cell-derived NK cell growth and differentiation through hyperosmosis. Stem Cell Research & Therapy. 14(1). 295–295. 13 indexed citations
5.
Chen, Wanqiu, Chenguang Wang, Zhi-Xue Yang, et al.. (2023). Reprogramming of human peripheral blood mononuclear cells into induced mesenchymal stromal cells using non-integrating vectors. Communications Biology. 6(1). 393–393. 4 indexed citations
6.
Wen, Wei & Xiao‐Bing Zhang. (2022). CRISPR–Cas9 gene editing induced complex on-target outcomes in human cells. Experimental Hematology. 110. 13–19. 20 indexed citations
7.
Yang, Zhi-Xue, Guohua Li, Feng Zhang, et al.. (2022). GREPore-Seq: A Robust Workflow to Detect Changes After Gene Editing Through Long-Range PCR and Nanopore Sequencing. Genomics Proteomics & Bioinformatics. 21(6). 1221–1236. 12 indexed citations
8.
Yang, Zhi-Xue, Ya-Wen Fu, Feng Zhang, et al.. (2022). Superior Fidelity and Distinct Editing Outcomes of SaCas9 Compared with SpCas9 in Genome Editing. Genomics Proteomics & Bioinformatics. 21(6). 1206–1220. 17 indexed citations
9.
Wen, Wei, Zhi-Xue Yang, Ya-Wen Fu, et al.. (2021). Effective control of large deletions after double-strand breaks by homology-directed repair and dsODN insertion. Genome biology. 22(1). 236–236. 45 indexed citations
10.
Zhang, Jianping, Zhi-Xue Yang, Feng Zhang, et al.. (2021). HDAC inhibitors improve CRISPR-mediated HDR editing efficiency in iPSCs. Science China Life Sciences. 64(9). 1449–1462. 20 indexed citations
11.
Qiu, Xingsheng, Xing Li, Anli Yang, et al.. (2021). CircGFRA1 facilitates the malignant progression of HER‐2‐positive breast cancer via acting as a sponge of miR‐1228 and enhancing AIFM2 expression. Journal of Cellular and Molecular Medicine. 25(21). 10248–10256. 58 indexed citations
12.
Fu, Ya-Wen, Xinyue Dai, Wentian Wang, et al.. (2020). Dynamics and competition of CRISPR–Cas9 ribonucleoproteins and AAV donor-mediated NHEJ, MMEJ and HDR editing. Nucleic Acids Research. 49(2). 969–985. 116 indexed citations
13.
Wen, Wei, et al.. (2019). Learning Efficient Sparse Structures in Speech Recognition. 2717–2721. 2 indexed citations
14.
Wen, Wei, Xinxin Cheng, Ya-Wen Fu, et al.. (2018). High-Level Precise Knockin of iPSCs by Simultaneous Reprogramming and Genome Editing of Human Peripheral Blood Mononuclear Cells. Stem Cell Reports. 10(6). 1821–1834. 17 indexed citations
15.
Li, Xiaolan, Guohua Li, Juan Fu, et al.. (2018). Highly efficient genome editing via CRISPR–Cas9 in human pluripotent stem cells is achieved by transient BCL-XL overexpression. Nucleic Acids Research. 46(19). 10195–10215. 80 indexed citations
16.
Wen, Wei, Jianping Zhang, Wanqiu Chen, et al.. (2017). Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors. Journal of Visualized Experiments. 12 indexed citations
17.
Zhang, Jianping, Xiaolan Li, Guohua Li, et al.. (2017). Efficient precise knockin with a double cut HDR donor after CRISPR/Cas9-mediated double-stranded DNA cleavage. Genome biology. 18(1). 35–35. 327 indexed citations
18.
Wen, Wei, Jianping Zhang, Jing Xu, et al.. (2016). Enhanced Generation of Integration-free iPSCs from Human Adult Peripheral Blood Mononuclear Cells with an Optimal Combination of Episomal Vectors. Stem Cell Reports. 6(6). 873–884. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026